Relationships between sarcopenia, depressive symptoms, and mild cognitive impairment in Chinese community-dwelling

Xiaoyu Chen1, Peipei Han2, Xing Yu2

  • 1Department of Rehabilitation Medicine, Shanghai University of Medicine and Health Sciences Affiliated Zhoupu Hospital, Shanghai, China; Department of Rehabilitation Medicine, Tianjin Medical University, Tianjin, China.

Abstract

Insights

Sarcopenia and depressive symptoms are linked to mild cognitive impairment (MCI) in older adults. Depressive symptoms mediate the relationship between sarcopenia and cognitive function, suggesting a complex interplay.

Area of Science:

  • Gerontology
  • Neurology
  • Public Health

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Understanding factors contributing to MCI is crucial for early intervention in older adults.

Purpose of the Study:

  • To investigate the association between sarcopenia (muscle mass, strength, physical performance) and depressive symptoms with MCI.
  • To explore the mediation pathways linking sarcopenia and depressive symptoms to MCI in older adults.

Main Methods:

  • A cross-sectional study of 1394 Chinese older adults (≥60 years).
  • Sarcopenia assessed using Asian Working Group for Sarcopenia (AWGS) criteria.
  • Depressive symptoms (GDS), cognitive function (MMSE, CDRS), and daily activities (IADL) were evaluated.

Main Results:

  • Sarcopenia, handgrip strength, gait speed, and depressive symptoms were significantly associated with MCI.
  • Depressive symptoms mediated the association between sarcopenia, handgrip strength, gait speed, and cognitive function.

Conclusions:

  • Sarcopenia may contribute to MCI development in older adults, potentially through depressive symptoms.
  • The findings highlight the importance of managing sarcopenia and depression for MCI prevention and treatment.